News at SPPI today

Discussion in 'Spectrum Pharmaceuticals' started by anonymous, Nov 23, 2016 at 2:15 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Agreed. If not our stock will become a penny stock
     

  2. anonymous

    anonymous Guest

    What about Riga , is he any good?


     
  3. anonymous

    anonymous Guest

    No good. Just a loud mouth backed by beu JT. Both should be out of sppi but before these sppi needs to clean it's dirt by removing unwanted Chinese and Indians they have there in abundance.
     
  4. anonymous

    anonymous Guest

    Happy New Year 2017. Today's News at Spectrum-

    Important Safety data was wrongly reported in two SAEs reported.

    ROLANTIS is not happening but Gajanan and team telling incorrect things to Raj and whole spectrum. ROLANTIS is way inferior to Neulasta and so we have filed for non-imferior but we desperately want it to be superior else we don't have a chance against many upcoming nuelasta generics. This was drug was already a rejected drug from Lily. Look their is no Phase 1 data reports or press release of ph-1 ROLANTIS or HM10460A which already proves trial was a failure. If you dig into this u will know the truth. Raj and Spectrum is fooling stockholders which we employees don't like.. somebody please do something...

    Now even Indian and Chinese people in spectrum wants to get rid of Raj but he is sticking to his position and not leaving.
     
  5. anonymous

    anonymous Guest

    Today's News-

    William Le, quit today.
    A clinical trial manager who is quiting 3rd time from spectrum. He was re-hired two times earlier within a span of 2 year gaps each time. Why? He manipulated trials for Raj.

    Late 2015 When Raj wanted someone to to fabricate clinical things retrospectively for a clinical audit for Apaziquone. He did same but drug failed miserably in ODAC 14 to 0 votes. He was a manager projects in a small CRO in Dallas but Raj made him Director in exchange of all Apaziquone DRAMA. Rightfully nothing worked and now he is quiting. Who knows Raj may bring him as a Vice President of clinical operations soon.


    Lot of sales rep and marketing people quit today. Total 16 of them. JT is busy collecting his fat paycheck. Doesn't care.

    Anil is constantly lying from Raj on many aspects.

    Gajanan is busy taking his paycheck for all lies and deciet in data manupulations by Data Managrment and keeping Raj happy. Poor Raj doesn't know ROLANTIS is a big failure and will not create any market.
     
  6. anonymous

    anonymous Guest

    William didn't quit today. His last day was Dec 30. Also, you have no proof he was manipulating data. William had nothing to do with ODAC or the data from the past studies used as part of the NDA and the ODAC presentation. You have some sort of sour grapes with the guy.

    Gajanan also didn't manipulate data. He performed an analysis of a subset of the data and from two studies. That's not manipulation. It's called statistics. If you want to argue about how that type of analysis is used in an NDA process then that's okay. The FDA clearly doesn't like hypothesis generating information as support for an NDA, but hypothesis generating processes have their place in scientific study. The better route would have been to use the analysis that Gajanan performed and designed a meaningful study, rather than also file the NDA and force the ODAC meeting. Additional advisory boards would have helped ensure the study design was appropriate.

     
  7. anonymous

    anonymous Guest

    I know all these dirty manupulations coz I was in quality department of spectrum and was part of a data audit happened just before ODAC. William Le & Gajanan Bhat did it right in front of me. Gajanan is still doing it. Their is no way in the world Apaziquone would have been approved. Last part of subset was twisted in both the phase-3 studies to show as if it had some signs but it was all fake.

    Raj carried the submission information so he can capitalize on positive movement of stock bcoz of Apaziquone news but,

    Gajanan did it purely of evil and to get promotions. Don't even let me start what did I saw at spectrum. They don't even follow basic quality requirements forget about anything good.

    Same manipulations thing they are doing with ROLANTIS which was bought from Hanmi Pharmaceuticals in just $1 million upfront and $238 million in milestone payment. Why? It's a failed drug. Check for phase 1 data or press release and you won't find any. Trial failed miserably in its phase 1 trials in Korea. Gajanan fabricated and submissive and spectrum did phase 2 and now doing phase 3.
    Hats of to these buggers!!!!!!!
     
  8. anonymous

    anonymous Guest

    Heard from a reliable source that Dr. Raj wants out to spend more time with family and that Joe T will take the CEO job.
     
  9. anonymous

    anonymous Guest

    This is exactly what Anil, Gajanan, Joe, Brent wants. Truly, only Pramod is the only Indian left with Raj. Even he is backstabbed by Anil many time but he don't know.
     
  10. anonymous

    anonymous Guest

    You nailed this one. The wednesday we were talking exactly the same shit while having lunch. All my Chinese friends from DM and PVG there agreed on it. They all considered Raj a brown little ugly fella.
     
  11. anonymous

    anonymous Guest

    Today's News

    Heads down Shoulders down. Nothing expected after ROLANTIS news.

    Checked online and found SPPI has sold bond worth $140 million plus stock dilation worth $75 million recently. That's $225 million. Total market cap today is $350 million. Using the real value and not hypothesis the actual SPPI worth seems to be $350 - $225 =>> $125 million. If any folks are good in maths check it out Yahoo finance and other news by urself.

    One more SAE filed wrongly from India was corrected today. Safety and DM are the big failures we have.
     
  12. anonymous

    anonymous Guest

    Sppi needs a CMO to cover-up their negligence and poor performance. Who wants to be a scapegaot?
     
  13. anonymous

    anonymous Guest

    Something is cooking -

    Anil and Gajanan were sent to India office while there is nothing constructed. Raj also went for a day there. Stock went up for no reason. No news out in market yet. Qapzola and ROLANTIS future hangs in midst of nowhere. More Asians are getting in while local Americans are thrown out of the company. Total Chaos, dont know what you believe and whom to believe.
     
  14. anonymous

    anonymous Guest

    Leadership is weak..Hedge, Miller and the rest of the Amgen flunkies are living in denial. Still using playbooks from the 1990's. Keep hiring your fellow Amgen friends as all the CAM's and OAM's exit. You can look around the room and keep patting each other on the back. Even Eagle wanted nothing more to do with Spectrum..Yeah we were gonna launch 5 products in 2016 lol..Its a sick cult nothing more. If they were any good at retaining top talent then why did half the salesforce leave two consecutive years in a row with 10,000 shares of "retention" stock on the table? You have CAMS covering from TN to DC and MA to Buffalo. Fun times!!
     
  15. anonymous

    anonymous Guest

    That's so true- sick cronyism at its worst. look at how many good people Lisa C drove out the fied force. she is the one that invented "Vacancy Management Program" they can't stand her she's a joke. Look at how they launched Evomela-- total cluster fu*$k Have to practically give it away now with all of the unanticipated generic competition- too late. And just what does a LAM/ RAM do???
     
  16. anonymous

    anonymous Guest

    Don't blame it to colleague or people one or two step higher than you. Evrything pours down from CEO level. Don't crib here, Either quit or complain it to SEC for compliant issues. Stop crying as you have no value..It's an Indian company.
     
  17. anonymous

    anonymous Guest

    Geesh if only you illiterate Indians could form complete sentences & use proper grammar lol. It is quite funny to read all of this HQ insider "Indian-on-Indian violence" bickering. But you're missing the bigger picture outside of your pathetic Irvine office. The SALES FORCE drives current revenue; not HQ. And when you have a corrupt VP of Sales like Lisa C at the helm, then this company is doomed to fail. With countless vacancies & sales force departures stacking up, the remaining lot is either still looking for another job or they're too incompetent to move on. I would call SPPI a sinking ship but that would insult the Titanic survivors. Get on board your life raft now & liquidate your stock units. The smart ones have long left this dysfunctional joke for a biotech company.
     
  18. anonymous

    anonymous Guest

    Wow, Qapzola devil will surely catch-up to Spectrum and it's Indian staff. This company needs a clean CEO and staff. Nepotism is at its highest in spectrum.
     
  19. anonymous

    anonymous Guest

    BOD's daughter and spy. AM is looking for the goods on Raj to take over
     
  20. anonymous

    anonymous Guest

    This is an eyeopener. Pramod's boy Vishal is in spectrum and he does work from westlake office & henderson. He is completely protected by Raj. Anil H also got such favors from Raj. Somebody even said that CEO has his own protected family in sppi everywhere. Examples are everywhere: Their VP Regulatory indian guy Anil is also their safety and then facilities guy. Their VP data management, biostat, medical writing is another Indian and relative. Their newest VP of investor relations is an indian. Their VP pharma ops is an Indian. Their VP strategic planning is an indian.
    Hello! Am I working here or in India?